Welcome to our dedicated page for Venus Concept SEC filings (Ticker: VERO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Venus Concept Inc. filings document the company’s transition out of public reporting, including Form 25 removal of its common stock from Nasdaq listing and Form 15 suspension of Exchange Act reporting obligations. The records also cover its common stock registration status, holder count at deregistration, and related corporate-status disclosures.
Recent Form 8-K filings describe material agreements with Madryn-affiliated lenders, including Main Street Priority Loan consents, Bridge Loan amendments, liquidity-waiver provisions, interest-payment treatment, and a debt-to-equity exchange into Series Y Convertible Preferred Stock. Other reports disclose quarterly financial results and FDA 510(k) clearance for Venus NOVA, tying regulatory events to the company’s medical aesthetic device business.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been previously registered. This step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. Together, these actions move the company away from U.S. public market reporting and capital-raising structures tied to those S-3 shelf registrations.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had previously been registered. This step follows a Board decision on January 20, 2026 to voluntarily delist the company’s common stock from the Nasdaq Capital Market and terminate its registration under U.S. federal securities laws.
The company also plans to suspend its duty to file periodic reports and other information with the SEC, meaning investors may receive less frequent and less standardized public financial disclosure going forward.
Venus Concept Inc. has filed post-effective amendments to multiple existing shelf registration statements on Form S-3 to deregister all securities that remain unsold under those registrations. This is an administrative step that removes unused capacity to issue securities that had previously been cleared for potential sale.
The company notes that its board of directors had previously approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports and other information with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. These actions collectively move Venus Concept away from being a U.S. exchange-listed and SEC-reporting company.
Venus Concept Inc. filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had previously been registered for potential sale. This step follows the board’s January 20, 2026 decision to voluntarily delist the company’s common stock from the Nasdaq Capital Market.
The board also approved suspending the company’s obligation to file periodic reports and other information with the SEC and terminating the registration of its common stock under U.S. federal securities laws. These changes collectively move Venus Concept toward operating as a non‑reporting, non‑exchange‑listed company in the United States.
Venus Concept Inc. filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been previously registered. This is an administrative step that removes unused shelf capacity for issuing securities to the public.
The company notes that its board of directors approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate registration of its common stock under U.S. federal securities laws. The amendments are signed on behalf of the company by its chief executive officer.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been available for future offerings. This administrative step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its SEC reporting obligations, and terminate registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. is filing a post-effective amendment to its Form S-1 registration statements to deregister all shares of common stock that were previously registered but remain unsold. This action also terminates the effectiveness of those registration statements as of the filing date.
The company’s board had earlier approved a plan to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate its U.S. federal registration. Ending these S-1 offerings and deregistering unsold shares aligns with that broader plan.
Venus Concept Inc. is filing a post-effective amendment to its Form S-1 registration statements to deregister all unsold shares of its common stock that had been registered for potential sale. This follows the board’s January 20, 2026 decision to voluntarily delist the common stock from the Nasdaq Capital Market and terminate its U.S. securities law registration obligations. With this step, the company formally ends all offerings under these S-1 registration statements and terminates their effectiveness.
Venus Concept Inc. entered into several financing agreements with Madryn Health Partners on January 29, 2026 to address near-term liquidity. A Consent Agreement under the Main Street Priority Loan waives certain minimum liquidity requirements through February 13, 2026 and allows the February 8, 2026 cash interest due under each Note to be applied to principal instead.
The company also signed a Twenty Fifth Bridge Loan Amendment, extending the Bridge Loan maturity date from January 31, 2026 to February 13, 2026, waiving certain minimum liquidity requirements through that date, and increasing the delayed draw commitment from $26,000,000 to $28,000,000. On the same day, Venus Concept completed a Seventeenth Delayed Drawdown of $2,000,000 under the Bridge Financing, which bears interest at 12% per year. The company plans to use net proceeds for general working capital needs.
The issuer has filed a Form 25 to remove the listing and registration of its common stock under Section 12(b) of the Securities Exchange Act of 1934. This step means its $0.001 par value common shares will no longer be listed and/or registered on the referenced securities exchange once the process is completed.